Catalyst Pharmaceuticals names chief commercial officer
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback
Infographic: The Big Picture 2023 Issuer & Investor Relations Outlook
Catalyst Pharmaceuticals Inc. appointed Daniel Brennan as chief commercial officer.
Brennan will lead the biopharmaceutical company's marketing, sales and commercial operations. He most recently served as COO at Edge Therapeutics Inc.
